Skip to main content
OpenTrials
Completed

NCT Number: NCT01583595

Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease

Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate).

Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Lung Disease Behavior Motor Activity Self-Efficacy

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women 40 years and older
  • Diagnosis of any chronic lung disease as evidenced by pulmonary function testing completed within the prior 12 months
  • Able to walk independently and successfully complete the 6-minute walk assessment

Exclusion criteria

  • Unable to walk without assistance or complete the 6-minute walk assessment
  • Patients unable to comprehend and accurately respond to the study questionnaires either by written or spoken communication
  • Patients diagnosed with or treated for a lower respiratory tract infection or COPD exacerbation within the prior 30 days

Treatment and study plan

Primary outcomes

  1. Analyze associations between self-efficacy for walking, gait speed, physical activity level and perceptions of symptoms in patient with chronic lung disease (COPD and Pulmonary Fibrosis)

    Time frame: Day of enrollment.

    Correlation , regression models and mediation analysis (self efficacy and physical activity) will be performed.

Secondary outcomes

  1. Predictive utility of 4-meter gait speed for estimating physical activity level (PAL) as validated by gold standard activity monitor.

    Time frame: 1 week

    Measure 4-meter gait speed during standardized 6 mintute walk test and compare to armband activity monitor results to determine predictive ability, if any, on PAL in people with chronic lung disease.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Determining the Relationships Between Self-efficacy for Walking Ability, Gate Speed and Physical Activity in Patients With Chronic Lung Disease

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Apr 24, 2012
Registry last updated
Apr 4, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.